The dopamine transporter counter-transports potassium to increase the uptake of dopamine

The dopamine transporter (DAT) facilitates dopamine reuptake from the extracellular space, and thereby terminates neurotransmission and rells cellular stores of dopamine. DAT belongs to the neurotransmitter:sodium symporter (NSS) family, which includes similar transporters for serotonin, norepinephrine, and GABA. A hallmark of NSS proteins is their ability to utilize the energy stored in the inward-directed Na+ gradient to drive the uphill transport of substrate. Decades ago, it was shown that the serotonin transporter also counter-transports K+, but investigations of K+-coupled transport in other NSSs have been inconclusive. Here, we show that the Drosophila dopamine transporter (dDAT) counter-transports K+. We found that ligand binding to both dDAT and human DAT is inhibited by K+ and that the conformational dynamics of dDAT in K+ is highly divergent from both the apo- and Na+-bound conformations. Furthermore, we found that K+ increased dopamine uptake by puried dDAT reconstituted in liposomes, and we visualized, in real-time, Na+ and K+ uxes in single proteoliposomes using uorescent ion indicators. Our results expand on the fundamentals of dopamine transport and prompt a reevaluation of the impact of K+ on other NSSs, including whether K+ counter-transport is a common mechanism for this pharmacologically important protein family.


Introduction
Dopaminergic signaling is involved in higher-order brain functions such as movement, mood, motivation, and learning 5,6 . The dopamine transporter (DAT) is responsible for the clearance of dopamine from the extracellular space and hence plays an important role in dopamine signaling intensity 6 . DAT malfunction has been associated with parkinsonism and ADHD 7,8 . In addition, DAT is the molecular target for pharmacological drugs such as methylphenidate, bupropion, and moda nil 1 , and the rewarding and addictive effects of psychostimulants are linked to their interaction with the transporter [9][10][11] . The compounds that target DAT are classi ed into inhibitors and substrates but the underlying differences in mechanisms of drug action are generally poorly understood, including the reverse transport mode induced by amphetamine 12 . A prerequisite for investigating the mechanisms of action of the drugs is to understand the basal transport mechanism of the transporters.
DAT belongs to the neurotransmitter:sodium symporter (NSS) family 2 , which also includes transporters of serotonin, norepinephrine, GABA, metabolites, and amino acids. It embraces species from eukaryotes, bacteria, and archaea. The NSSs share a common structural fold consisting of 12 transmembrane segments (TMs) connected by extracellular-(EL) and intracellular (IL) loops 13 . Transport is proposed to occur by a rocking-bundle mechanism, where the central binding site for substrate and ions is alternatingly accessible to either side of the membrane, caused by the movement of TM 1, 2, 6, and 7, relative to TMs 3, 4, 8, and 9 14 .
It has been long known that the serotonin transporter (SERT) in addition to the symport of Na + possesses a counter-transport of K + . The K + counter-transport is permissive and increases the k cat for serotonin 15 . This feature is thought to be unique for SERT. However, we have observed an effect of K + on the transport properties and conformational state of LeuT -a prokaryote NSS [16][17][18] . Although still controversial 19 , it opens for the possibility that K + counter-transport might be an evolutionary preserved mechanism within the NSS family that previously have been overlooked. K + shows competitive binding relative to Na + To address this aspect of the NSS mechanism, we turned to the Drosophila DAT (dDAT) 20,21 . Dopamine a nity and transport rate by dDAT is comparable to human DAT (hDAT), and the pharmacological pro le of dDAT lies between that of hDAT and the human NET 22 . Using dDAT, we investigated whether K + is a component in dopamine transport.
The potent NET inhibitor [ 3 H]nisoxetine binds dDAT with high a nity (Extended Data Fig. 1a) 22 . If a K + binding site exists in dDAT with similar mechanistic features as observed for SERT 23 and LeuT 16 , it should exclude substrate binding and be competitive to Na + . To address this, we expressed full-length dDAT-8-His protein in suspension HEK293 cells (Expi293F) using the BacMam system 24,25 and puri ed the transporter 20 . We probed the Na + -dependence of [ 3 H]nisoxetine binding to dDAT in mixed detergentlipid micelles (Fig. 1a). We found that Na + supports the binding of 120 nM [ Fig. 1b). We then included various K + concentrations and found that K + dose-dependently decreased the EC 50 value for Na + -dependent [ 3 H]nisoxetine binding ( Fig. 1a and Extended Data Table 1). A Schild plot analysis 26 of the change in EC 50 values as a function of added K + , estimated the a nity (K B ) for K + to 102 [100;105] mM (mean [SEM interval]). The slope of the linear regression in the plot was not signi cantly different from 1 suggesting that K + acts as a competitive inhibitor of Na + binding (Fig. 1b).
We next assessed whether the inhibitory effect of K + is shared between dDAT and hDAT. We expressed hDAT in Expi293F cells, harvested the membranes, and measured the Na + -dependent [ 3 H]  binding to hDAT in the presence and absence of K + (Fig. 1c) K + induces overall stabilization of dDAT structural dynamics If dDAT possesses a K + binding site with implication for function, then K + binding would be expected to impact the dynamics of dDAT structure. To investigate this, we probed the in uence of K + on the overall conformational dynamics of dDAT by hydrogen-deuterium exchange MS (HDX-MS). The rate of hydrogen/deuterium exchange (HDX) of backbone amide hydrogens correlates with the speci c hydrogen bonding of higher-order protein structure 20,28 . For instance, if the binding of an ion stabilizes the region of a protein, it will typically be re ected in the HDX pro le of that region. Accordingly, we probed the solutionphase HDX pro le of puri ed dDAT in mixed micelles in 200 mM KCl. The time-dependent HDX was monitored for 85 identi ed dDAT peptides 20 covering ~77 % of the protein sequence (Fig. 2, Extended Data Table 2 & 3), thus providing us with a comprehensive view of the structural dynamics of the protein (Extended Data Fig. 2).
We compared the HDX data of dDAT in the presence of 200 mM K + relative to a control buffer of similar ionic strength where K + was substituted with Cs + . We found that many regions of dDAT underwent decreased HDX in the K + -containing buffer, which indicated widespread stabilization of dDAT structural dynamics by K + relative to Cs + (Fig. 1a, b and Extended Data Fig. 2, 3a). The stabilizing effects were localized to the core domain (TM1, 2, 6, and 7) and minor parts of TM10, 12, and the C-helix, as well as the EL1, 2, 3, 4, and IL3, 4, 5. The K + stabilizing effect was mainly located to regions suggested to be involved in the substrate transport process as also observed previously for Na + in dDAT 20 . This K +induced stabilization of distinct, functionally relevant regions of dDAT indicates a speci c K + binding site in the transporter.
The comparison of the HDX pro le of dDAT in Na + -versus the K + -state revealed that even though both ions impact the conformational dynamics in many of the same regions, the differences in HDX (ΔHDX) are of opposing magnitude for several regions (Fig. 2c, d and Extended Data Fig. 2, 3b). This argues against that K + simply substitutes for Na + and induces a Na + -bound conformation. Relative to Na + , K + induced structural stabilization of TM1b, part of the hinge region of TM1, parts of TM7, and in loop regions on the extracellular side in EL2, 3, 4 and 6. In contrast, most intracellular regions were destabilized in K + compared to the Na + state. Speci cally, TM1a, TM6b, IL3, the intracellular part of TM7, and IL4 along with the intracellular parts of TM8 and TM9, showed increased dynamics in the K + state. Increased dynamics were also observed on the extracellular face of the transporter in EL2, part of EL3, and TM6a. The higher degree of stabilization on the extracellular face and intracellular destabilization, could suggest that K + induces a more inward facing dDAT state than Na + . dDAT transport of dopamine into proteoliposomes is increased by K + To explore the functional relevance of K + to dopamine transport, we reconstituted puri ed dDAT into liposomes with tight control of the intra-vesicular ionic content. The reconstituted dDAT transported [ 3 H]dopamine into the lumen of the proteoliposomes (PLs) in the presence of an inward-directed Na + gradient (Fig. 3a). No dopamine uptake was observed in the presence of the inhibitor nortriptyline, or when the Na + gradient was dissipated (Extended Data Fig. 4a).
We then compared [ 3 H]dopamine transport activity from vesicles containing intra-vesicular K + to vesicles containing either Cs + or NMDG + . At all times, chloride was used as the corresponding anion. Uptake data were correlated to the total amount of active dDAT in the reconstituted system (Extended Data Fig. 4b). The inwardly directed Na + gradient could drive dopamine uptake regardless of the intravesicular cation, but the concentrative capacity decreased to about 20 % when K + was substituted with either Cs + or NMDG + (Fig. 3a and Extended Data Table 4). The transport kinetics were further investigated by [ 3 H]dopamine saturation uptake experiments (Fig. 3b). The K m for [ 3 H]dopamine was comparable to previous observations of dDAT in intact cells 29 (Extended Data Table 5). However, we observed a signi cant decrease in transport velocity, when the intra-vesicular K + concentration was lowered from 200 mM to 150 and 100 mM, suggesting that the V max of dopamine transport is dependent on intra-vesicular K + . We also observed a drop in transport velocity when we dissipated the K + gradient, by having 100 mM K + on both sides (Fig. 3c), suggesting that the K + gradient contributes with a driving force for dopamine transport.
Time-resolved ux of Na + and K + mediated by dDAT To obtain a more direct measure of dDAT mediated ionic ux, we followed in real-time, the change in intra-vesicular ion concentration in a single vesicle setup. The PLs were tethered on a surface by biotinylated lipids and visualized with ATTO-665 membrane dye using total internal re ection uorescence microscopy (TIRFm) [30][31][32] . To examine the ion ux we encapsulated either a uorescent Na + indicator (Sodium Green™, Tetra (Tetramethylammonium) Salt) or a uorescent K + indicator (ION Potassium Green-2 TMA+ salt) in the PLs (Extended Data Figure 5a-c). The PLs were passivated on a glass surface at the bottom of a ow cell. This allowed us to measure the relative changes in ion concentrations inside individual PLs as a function of the intensity change of the uorescence signal from the indicators (Fig. 4a). The procedure maintains the spherical morphology and structural integrity of the liposomes 30,31 and uptake of [ 3 H]dopamine was maintained (Extended Data Fig. 5d,e and 6).
We evaluated how PLs containing the Na + indicator responded to the application of external Na + and dopamine (Fig 4b). About half of the detected vesicles responded to the application of Na + and dopamine with an exponential increase in uorescence intensity from the indicator followed by a plateau (Fig. 4b, c), indicating an expected increase in intra-vesicular Na + concentration during dopamine uptake. The number of responding vesicles decreased to about half when only Na + was added into the ow cell, indicating that a fraction of the PLs would take up Na + even in the absence of dopamine. Nortriptyline (500 µM) blocked Na + uptake within the timeframe of the experiment, con rming that our observations are dDAT-mediated. We did not detect passive Na + leakage through the lipid bilayer (Fig. 4c). After reaching the plateau, the uorescence intensity of the Na + indicator decreased. We consider this an inherent property of the indicator associated with inner lter effect (Extended Data Fig. 6e) disconnected from the Na + in ux, and was therefore not included in the further calculations.
The measurement of DAT-mediated Na + ux into single PLs, lead us to proceed with the K + -indicator to determine whether the application of Na + and dopamine would in uence K + ux. To follow the intravesicular level of K + , the K + -indicator was encapsulated in PLs containing 100 mM K + and 100 mM NMDG + . Introduction of external buffer containing dopamine, 100 mM Na + , and 100 mM K + trigged an exponential decrease in the signal from the K + -indicator, suggesting an e ux of K + ions (Fig. 4b). The persistent recording of K + ux in the absence of a K + gradient supports the suggestion of a K + countertransport. Surprisingly, the fraction of responding liposomes was in this case not affected by dopamine.
However, the response was blocked by nortriptyline, suggesting that the K + e ux is dDAT-mediated (Fig.   4d).
The rates of Na + and K + ux across the membrane are increased by dopamine The time-resolved nature of the uorescence change in the single-vesicle setup allowed us to investigate the Na + and K + ux rates in individual active PLs. We rst evaluated how Na + transport rates were affected by dopamine and K + . In vesicles reconstituted with NMDG + , dopamine did not signi cantly affect the Na + in ux rate (Fig. 4e). In contrast, in vesicles containing K + , the addition of dopamine signi cantly increased the Na + in ux rate (Fig. 4f). When comparing the dopamine-dependent Na + in ux rates between vesicles with NMDG + and with K + , we found that the Na + in ux rates were increased markedly by K + (Fig. 4g). This suggests that the Na + in ux associated with dopamine uptake is increased by K + . In the absence of dopamine, the rates of Na + ux were not different between vesicles containing either K + or NMDG + (Extended Data Fig. 7), suggesting that dopamine-independent Na + ux is unaffected by the identity of the intra-vesicular ion.
Next, we looked at the individual uorescence traces from liposomes loaded with uorescent K +indicator. In line with our observations from the Na + -indicator, we also here observed a signi cant decrease in the rate of uorescence intensity from the K + indicator, suggesting an increase in K + e ux rates in the presence of dopamine (Fig. 4h). Taken together, the results from the single vesicle setup suggest that the number of vesicles responding with a Na + in ux is increased with dopamine. For K + it is rather the rate of e ux and not the number of responding vesicles that are affected by dopamine. The correlation between the increase in rates of both Na + transport and K + counter-transport in the presence of dopamine is coherent with our suggestion that the coupling of K + to dopamine transport increases the rate of uptake.

Discussion
We have studied the effect of K + on the molecular, pharmacological, and functional properties of DAT. We showed real-time ion transport by dDAT, visualized in single vesicles resolution. All assays were performed with full-length dDAT avoiding possible artifacts from mutations or chemical protein modi cations, often necessary in biophysical assays. Across methods, our results are consistent with the suggestion that K + takes part in dDAT-mediated dopamine transport. Our Schild plot shows that K + binds to dDAT with an a nity of about 100 mM, which is within a physiological concentration range for resting neurons.
Our HDX-MS data revealed that K + induces a conformational state that is distinct from both the dDAT apo-and Na + -state. K + decreases stability mainly on the intracellular face of dDAT and stabilizes several extracellular regions. The K + state is coherent with a mechanism in which K + binding promotes an inwardfacing dDAT conformation allowing the release of Na + and substrate on the intracellular side. It is also in agreement with the proposed K + states of both SERT 33 and LeuT 17 as observed using HDX-MS.
Functionally, intra-vesicular K + causes an increase in the uptake capacity and uptake rate of dopamine relative to vesicles containing intra-vesicular Cs + or NMDG + , and this increase is unrelated to the level of active transporters in the vesicles. This suggests that the function of K + is to decrease the rate-limiting step in the dDAT transport cycle or to inhibit the rebinding of Na + and dopamine, which otherwise can obstruct the progression of the transport cycle or even promote reverse transport. The latter has been suggested as the role for K + in LeuT 16 .
We cannot rule out that a fraction of the reconstituted dDAT is in the inside-out orientation. However, when imposing an inward-directed Na + gradient we promote unidirectional transport.
The reconstitution in PLs also allows the encapsulation of uorescent sensors such as the Na + and K + indicators. We were able to visualize the movement of ions across the membrane by dDAT in the single vesicles. We saw that Na + and K + transport could be uncoupled from dopamine transport. Both hDAT and SERT have been shown to possess both uncoupled currents and leak currents not associated with transport 34,35 . The constitutive dopamine-independent ux of Na + and K + could be parallel to the leak currents measured by electrophysiology 35 . When dopamine was added externally, it increased the rate by which K + was counter-transported. When both dopamine and K + was present on the external and intra-vesicular side respectively, the rate of Na + uorescence increased, and correlated with a decrease in K + uorescence. The observation is coherent with a transport-mechanism where Na + and dopamine uptake became coupled with K + counter-transport.
Our results suggest that K + counter-transport is a signi cant component of the dopamine reuptake mechanism of dDAT. It is permissive but not obligate for dopamine transport. The effects observed here align with observations on SERT 4 and LeuT 16,17 , linking our results to both an evolutionary close -and a distantly related NSS, respectively. The pharmacological data presented on hDAT opens the possibility that K + also here could have a similar effect. Taken together, this suggests that K + counter-transport is more common among the NSS family of transporters than previously anticipated and could be a rule rather than the exemption. In the broader perspective, understanding the NSS transport mechanism in molecular detail forms part of the basis for guiding the development of drugs that modulate the transporters. Furthermore, it could be important for precision medicine by allowing prediction of the functional implications of transporter single nucleotide polymorphism in individuals suffering from neuropsychiatric disorders 7

Methods
Protein expression and puri cation. Full-length dDAT was produced using baculovirus-mediated transduction of Expi293F suspension cells and puri ed as previously described 20 . Brie y, membranes were prepared by sonication, homogenized and solubilized in buffer containing 20 mM Tris, pH 8.0, 150 mM NaCl, 20 mM n-dodecyl β-D-maltoside (DDM), 4 mM cholesteryl hemisuccinate (CHS), 5 µg/ml benzamidine, and 10 µg/ml leupeptin. Detergent-solubilized dDAT was incubated with nickel-charged metal a nity resin, and washed in buffer containing 40 mM Tris, pH 8.0, 300 mM NaCl, 5% glycerol, 14 µM lipids (POPC, POPE, and POPG at a weight ratio of 3:1:1), 1 mM DDM, 0.2 mM CHS supplemented with 5 µg/ml benzamidine and 10 µg/ml leupeptin with a gradient of imidazole. The protein was eluted from the a nity column with buffer supplemented with 300 mM imidazole. The protein was spinconcentrated and loaded on a FLPC size exclusion column to increase purity and remove imidazole from the buffer. Finally, the protein was spin-concentrated and stored at -80°C for further use. All procedures were performed on ice or at 4°C.
Full-length hDAT was expressed using the same approach as for dDAT. The cells were harvested, and membranes were prepared by sonication in buffer containing 30 mM NaHEPES pH 8.0, 30 mM NaCl, 5 mM KCl, 5 mM Ethylenediaminetetraacetic acid (EDTA), 7 mM MgCl 2 , 10% (w/v) sucrose, 5 µg/ml benzamidine, 10 µg/ml leupeptin, PI, 2 µg/ml DNase I, and 2 µg/ml RNase A. The membranes were pelleted by ultracentrifugation and washed in buffer containing 30 mM NaHEPES pH 8.0, 1 M NaCl, 5 µg/ml benzamidine, 10 µg/ml leupeptin, PI and 10 mM DTT by homogenization. This step was repeated twice. The membranes were homogenized in a 30 mM NaHEPES pH 8.0, 30 mM NaCl, 5 mM KCl, 10% (w/v) sucrose and 10 mM DTT buffer and stored at -80°C. All steps were performed on ice or at 4°C.  Samples were stored at -80°C until further use. All time points were performed in triplicate. The isotopic exchange was performed simultaneously with the Cs + and Na + states as described previously 20 .
Prior to mass analysis, quenched samples were rapidly thawed and injected into a cooled (0°C) nanoACQUITY UPLC HDX system (Waters). Protein samples were digested online at 20°C on an in-house packed immobilized pepsin column prepared using pepsin agarose resin (Thermo Fisher scienti c). The resulting peptides were rapidly desalted on a C8 trap column (VanGuard pre-column ACQUITY UPLC BEH C8 1.7 µm, Waters) for 3 min at a ow rate at 200 µl/min solvent A (0.23% formic acid in water, pH 2.5) and separated by reversed-phase chromatography over a C8 analytical column (ACQUITY UPLC BEH C8 1.7 µm, 100 nm, Waters) with a C8 trap column in front using a linear gradient from 8 -30% solvent B (0.23% formic acid in acetonitrile) over 10 min at a ow rate of 40 µl/min. Mass analysis was conducted on a hybrid Q-TOF SYNAPT G2-Si mass spectrometer (Waters) equipped with a standard ESI source operated in positive ion mode. Mass spectra were lock-mass corrected against Glu-brinopeptide B. Ion mobility separation was used to enhance peak capacity and minimize spectral overlap.
HDX-MS data for the K + state was acquired simultaneously with the Cs + and Na + states previously reported 20 . Maximum-labeled control samples shown here are from our previous study 20 , and thus, were prepared, processed and analyzed as earlier described. Peptide identi cation from non-deuterated samples is also described in our previous study 20 .
HDX-MS data evaluation and statistical analysis. The deuterium exchange levels were calculated for all identi ed peptides using DynamX 3.0 (Waters) with manual veri cation of all peptide assignments. Noisy and overlapping spectral data were discarded from the HDX-MS analysis. To allow for quantitative comparison of samples not measured on the same day, back-exchange was calculated and used to normalize deuterium uptake values between measuring days as previously described 20 . Also as described previously 20 , the deuterium uptake of individual states were compared for all identi ed peptides in Microsoft Excel (Microsoft) using either a homoscedastic or a heteroscedastic Student's t test (α = 0.01) depending on an F-test (α = 0.05) that compared the variance of deuterium uptake from two different states for each single peptide at a single time point. For each peptide, a difference in HDX between two states was only considered signi cant if two consecutive time points showed a signi cant difference in deuterium uptake (p < 0.01). Furthermore, differences in HDX between the Cs + and K + states and the Na + and K + states had to exceed threshold values of 0.24 Da and 0.20 Da, respectively, which corresponded to the 95% con dence interval (CI) calculated according to: Here is the average difference in deuterium content assuming a zero-centered distribution (x = 0), t is 4.303 for the 95% CI with 2 degrees of freedom, σ is the pooled propagated standard deviation of differences in deuterium content for all peptides across all time points (i.e. 0.25 -480 min) for the two states compared, and n is the number of replicate samples (n = 3). HDX results were mapped onto the dDAT crystal structure (PDB ID: 4XP1) using PyMOL.
The HDX Summary Table (Extended Data Table 2) and the HDX Data Table (Extended Data Table 3) are included according to the community-based recommendations for HDX data availability 37 .
Reconstitution of dDAT into liposomes. Liposomes were prepared from asolectin:cholesterol:brain polar lipid extract (Avanti) in molar ratio 60:17:20 in buffer (20 mM HEPES (pH 7.5), 200 mM KCl). The lipid mix was dried under a stream of N 2 for 2 h. The lipid lm was suspended in buffer to 10 mg lipid/ml by alternating vortexing and bath sonication. The liposomes went through ve freeze-thaw cycles, and were extruded with a mini extruder(Avanti) through a polycarbonate lter with 400 nm pore size. The liposomes were diluted to 4 mg lipid/ml and mixed with puri ed dDAT (protein concentration in storage buffer, 2 mg/ml) in a 1:150 protein:lipid (wt/wt) ratio. After 30 min incubation under slow rotation at 7℃, SM-2 bio-beads equilibrated in buffer (20 mM HEPES (pH 7.5), 200 mM KCl) were added in a 35 mg (semi-dry)/ml beads to buffer ratio. SM-2 bio-beads were added again after 30 min, after 60 min and after 15 h. After the last addition, beads and PLs incubated for 2 h. Between additions, the sample incubated at 7℃ under slow rotation. Bio-beads were removed by ltration. The proteoliposome (PL) sample was split into centrifugation tubes and diluted 25 times in the nal intra-vesicular buffer (200 mM chloride salt, 20 mM HEPES (pH 7.5)) and spun at 40,000 rpm (Thermo Scienti c, T-865 xed angle rotor) for 1 h at 4℃.
Subsequently, the pelleted PLs were re-suspended to 10 mg lipid/ml in their nal intra-vesicular buffer, and frozen in liquid N 2 in appropriate aliquots until use. PLs for TIRFm were made as described with the following additions to the protocol. In the lipid mix 1:1000 molecular ratio of biotinylated PEG-DOPE and ATTO-655-DOPE was added. At all times, the sample was shielded from light to protect the uorophores.
After two freeze-thaw cycles the liposomes were split in two, and 10 mM Na + -sensor (Sodium Green™, Tetra (Tetramethylammonium from ThermoFisher) Salt or K + -sensor (ION Potassium Green-2 TMA+ Salt from Abcom) was added. Where p is the maximal uptake (the amplitude) and k is the rate constant in min -1 , t is time in min and y is uptake in c.p.m. after normalization to transporter concentration. Subsequently, data from each experiment were normalized to the value of p from the condition with the highest maximal uptake. The normalized data sets from each experiment were combined and re-tted to the one phase association.
For concentration dependent uptake, the data were normalized to dDAT activity from each condition.
Non-speci c [ 3 H]dopamine binding measured in the absence of a Na + gradient was subtracted.
Normalized speci c uptake data were tted to the Michaelis-Menten equation. Subsequently, the data were normalized to the V max value determined from the condition with the highest V max . The normalized data sets from each experiment were combined and re-tted to the Michaelis-Menten TIRF recordings of single proteoliposome assay. Glass surfaces were prepared using plasma cleaned glass slice with fastened sticky-Slide VI 0.4 from Ibidi and functionalized using PLL-g-PEG and PLL-g-PEG-biotin in a 100 to 1 ratio followed by a neutravidin layer 30,31 . Each glass surface contains 6 chambers that are independently utilized for liposomes immobilization and imaging. The liposomes were owed into the selected microscope chamber using the pump setup for immobilization to obtain a liposome density of 200-250 liposomes per eld of view. Unbound liposomes were washed away with 3x chamber volumes of buffer. Using CellSens imaging software from Olympus, the image recordings were fully automated. Brie y, we recorded a 6-eld of view in parallel with a temporal resolution of 3.7 sec/cycle for Na + uptake and 3.4 sec/cycle for K + out ow with a total of 700 cycles per experiment corresponding to a total experimental timeframe of 43 -40 minutes, respectively. Real-time recording was started with the same buffer in the ow cell as inside the PLs, then the buffer was exchanged using the pump for the 0.5 mL of the respective uptake buffer with a owrate of 0.5 mL/min.
Compositions for uptake and intra-proteoliposomal buffers and substrate concentration for TIRF recording. Monitoring the outward K + transport, the intra-proteoliposomal buffer was composed of: 10 mM ION Potassium Green-2 TMA+ Salt, 20 mM HEPES, 100 mM KCl, 100 mM NMDG-Cl. Uptake buffer contained: 20 mM HEPES, 100 mM KCl, 100 mM NaCl, 1 mM L-ascorbic acid, 1 mM EDTA. Monitoring the inward transport of Na + , two populations of liposomes with two distinct intra-proteoliposomal buffers were prepared as to observe the dependence of K + . Intra-proteoliposomal buffer with K + was composed of: 10 mM Sodium Green™, Tetra (Tetramethylammonium) Salt, 20 mM HEPES, 100 mM KCl, 100 mM NMDG-Cl. Intra-proteoliposomal buffer without K + contained: 10 mM Sodium Green™, Tetra (Tetramethylammonium) Salt, 20 mM HEPES, 200 mM NMDG-Cl. Uptake buffer was composed of: 20 mM HEPES, 200 mM NaCl, 1 mM L-ascorbic acid, 1 mM EDTA. The concentration of dopamine in the uptake buffers was 0.5 µM, while the concentration of the inhibitor nortriptyline was 500 µM. All buffers were adjusted to pH 7.5, and freshly prepared on the day of the experiment.
Tracking and co-localization software for TIRF multiplexing experiments. All individual liposomes were localized and tracked using the membrane signal from the ATTO 655 membrane dye and co-localized to the ion indicator signal. Tracking and localization was done using in-house developed python software based on previous publications 31, 32 to ensure a nanometer precise localization and co-localization whilst simultaneously correcting for any potential x, and y drift introduced by the pump. Using an adapted version of previously published software 31 , the background corrected signal from both the membrane dye and ion indicator were extracted to ensure correct signal integration.
Fitting single data to single exponential decay. After signal extraction, all active traces were found by manual selection and the corresponding translocation rates determined using a maximum likelihood tting scheme as previously described 30,32 . For K + experiments, the decreasing intensity traces were tted with Where p is the amplitude, k is the rate constant and y represents the offset from zero. For Na + experiments, the increasing intensity traces were tted with Where p is the amplitude, k is the rate constant and y represents the offset from zero.

Supplementary Files
This is a list of supplementary les associated with this preprint. Click to download. SchmidtetalKaffectsdDATactivityExtdData.docx